Skip to content
10-Q

Quarterly Report

RESEARCH FRONTIERS INCORPORATED REFR

0001641172-25-009244

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 8, 2025 33.65M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.35M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $1.99M
Current Liabilities Q1 2025 · Mar 31, 2025 $210.71K
Current Liabilities Q1 2025 · Dec 31, 2024 $269.03K
Total Liabilities Q1 2025 · Mar 31, 2025 $1.34M
Total Liabilities Q1 2025 · Dec 31, 2024 $1.44M
Current Assets Q1 2025 · Mar 31, 2025 $2.52M
Current Assets Q1 2025 · Dec 31, 2024 $2.75M
Total Assets Q1 2025 · Mar 31, 2025 $3.77M
Total Assets Q1 2025 · Dec 31, 2024 $4.04M
Shares Diluted Q1 2025 · Mar 31, 2024 33.51M sh
Capex Q1 2025 · Mar 31, 2024 $50
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$391.12K
Stockholders Equity Q1 2025 · Mar 31, 2024 $3.08M
Stockholders Equity Q1 2025 · Dec 31, 2023 $3.52M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.01
Eps Basic Q1 2025 · Mar 31, 2024 −$0.01
Rd Expense Q1 2025 · Mar 31, 2024 $149.74K
Net Income Q1 2025 · Mar 31, 2024 −$442.6K
Operating Income Q1 2025 · Mar 31, 2024 −$469.75K
Revenue Q1 2025 · Mar 31, 2024 $313.38K